Earnings Call Summary | American Oncology Network(AONC.US) Q1 2024 Earnings Conference
Earnings Call Summary | American Oncology Network(AONC.US) Q1 2024 Earnings Conference
The following is a summary of the American Oncology Network, Inc. (AONC) Q1 2024 Earnings Call Transcript:
以下是美國腫瘤網絡公司（AONC）2024年第一季度業績電話會議記錄摘要：
Financial Performance:
財務業績：
American Oncology Network reported Q1 2024 revenue of $364.3 million, up by 20% from $303.7 million for the last year's same period.
Revenue increase was largely due to a 12.8% rise in revenue per encounter and a 6.2% increase in patient encounters.
The company, however, witnessed a net loss before non-controlling interest of $24.9 million for Q1 2024 compared to $1.5 million for Q1 2023.
Adjusted EBITDA for Q1 2024 came down by $2 million from the same period last year to reach $2 million.
The company retained total liquidity of $132.7 million by the end of Q1 2024.
美國腫瘤網絡報告稱，2024年第一季度收入爲3.643億美元，較去年同期的3.037億美元增長了20％。
收入的增長主要是由於每次接觸的收入增長了12.8％，患者就診量增長了6.2％。
但是，該公司2024年第一季度扣除非控股權益的淨虧損爲2490萬美元，而2023年第一季度爲150萬美元。
2024年第一季度調整後的息稅折舊攤銷前利潤比去年同期下降了200萬美元，達到200萬美元。
截至2024年第一季度末，該公司保留了1.327億美元的總流動性。
Business Progress:
業務進展：
AON continued to execute growth plans and strategic priorities including two practice acquisitions in Q1 2024 and announcement of two more early Q2 2024.
The company welcomed 17 new providers to the AON platform, making the total 40 year to date.
AON expanded its presence in Texas and Maryland, and made strategic expansions in Hawaii and Georgia in April.
In April, AON launched MiBA, a healthcare technology firm to service the pharmaceutical industry and optimize healthcare treatments.
AON achieved best-in-class net promoter scores with 75% or more from physicians and team members and over 90% from patients.
As of Q1 2024, AON partnered with over 240 providers spanning 21 states plus the District of Columbia.
AON acknowledged the contributions of outgoing CFO David Gould and announced Dave Afshar as the Interim CFO.
怡安繼續執行增長計劃和戰略重點，包括2024年第一季度的兩次業務收購，以及2024年第二季度初宣佈的另外兩項業務收購。
該公司歡迎17家新提供商加入AON平台，使迄今爲止的總數達到40年。
怡安擴大了在德克薩斯州和馬里蘭州的業務，並於4月在夏威夷和佐治亞州進行了戰略擴張。
4月，怡安成立了醫療保健技術公司MiBA，旨在爲製藥行業提供服務並優化醫療保健治療。
AON獲得了同類最佳的淨啓動子分數，來自醫生和團隊成員的淨啓動子分數達到75％或以上，來自患者的淨啓動子分數超過90％。
截至2024年第一季度，怡安與遍佈21個州和哥倫比亞特區的240多家提供商合作。
怡安感謝即將離任的首席財務官戴維·古爾德的貢獻，並宣佈戴夫·阿夫沙爾爲臨時首席財務官。
Tips: For more comprehensive details, please refer to the IR website. The article is only for investors' reference without any guidance or recommendation suggestions.
提示：欲了解更多詳情，請訪問投資者關係網站。本文僅供投資者參考，不構成任何投資建議。
譯文內容由第三人軟體翻譯。